Apixaban in Comparison to Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies.

Muhammad Umer SiddiquiDavid ScalzittiZunaira Naeem

Published in: Cardiology research and practice (2019)

Apixaban is superior to warfarin in terms of safety, but no difference in efficacy is noted. The choice of anticoagulation should be individualized based on the risk factor profile of the patient.

Keyphrases

atrial fibrillation
oral anticoagulants
direct oral anticoagulants
catheter ablation
left atrial
left atrial appendage
risk factors
heart failure
case report
percutaneous coronary intervention
coronary artery disease
brain injury
clinical evaluation